CSF3 and neutropenia: Neutropenia is typically treated as an emergency and, in a subset of patients, the risk of neutropenia may be prophylactically addressed with post‐HSCT subcutaneous injection of recombinant human G‐CSF (filgrastim) to facilitate recovery.6, 14, 17, 18